Latest On Applied Genetic Technologies Corporation (AGTC):
About Applied Genetic Technologies Corporation (AGTC):
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's advanced product candidates consist of three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which has completed Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate for the patients with advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and three preclinical programs in targeting central nervous system disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, and adrenoleukodystrophy. It has collaboration agreements with Synpromics Limited; University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida.
General
- Name Applied Genetic Technologies Corporation
- Symbol AGTC
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 83
- Fiscal Year EndJune
- IPO Date2014-03-27
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.agtc.com
Valuation
- Price/Sales (Trailing 12 Mt.) 57.95
- Price/Book (Most Recent Quarter) 5.22
- Enterprise Value Revenue 70.49
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.96
- Next Year EPS Estimate -$1.73
- Next Quarter EPS Estimate -$0.46
- Return on Assets -46%
- Return on Equity -111%
- Earnings Per Share -$0.11
- Revenue Per Share $0
- Gross Profit -13933000
- Quarterly Earnings Growth -100%
Highlights
- Market Capitalization 245.28 million
- EBITDA -3077000
- Analyst Target Price $16
- Book Value Per Share $1.60
Share Statistics
- Shares Outstanding 42.66 million
- Shares Float 36.25 million
- % Held by Insiders 102%
- % Held by Institutions 68.32%
- Shares Short 2.36 million
- Shares Short Prior Month 1.63 million
- Short Ratio 0.36
- Short % of Float 6%
- Short % of Shares Outstanding 6%
Technicals
- Beta 2.28
- 52 Week High $9.67
- 52 Week Low $2.8
- 50 Day Moving Average 5.45
- 200 Day Moving Average 5.04
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Applied Genetic Technologies Corporation (AGTC) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Applied Genetic Technologies Corporation (AGTC) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-02-11 | $N/A | -$0.60 | -$0.57 | -4.95% |
2020-09-30 | 2020-11-16 | $N/A | -$0.60 | -$0.51 | -16.89% |
2020-06-30 | 2020-09-09 | $N/A | -$0.56 | -$0.46 | -22.27% |
2020-03-31 | 2020-05-13 | $N/A | -$0.50 | -$0.54 | 7.41% |
2019-12-31 | 2020-02-05 | $2.45 million | -$0.47 | -$0.59 | 20.07% |
2019-09-30 | 2019-11-12 | $N/A | -$0.64 | -$0.63 | -2.4% |
2019-06-30 | 2019-09-26 | $406000 | -$0.58 | -$0.42 | -38.1% |
2019-03-31 | 2019-05-07 | $21.32 million | $0.63 | -$0.53 | 218.87% |
2018-12-31 | 2019-02-07 | $5.93 million | -$0.23 | -$0.70 | 67.14% |
2018-09-30 | 2018-11-08 | $14.03 million | -$0.48 | -$0.48 | 0.81% |
2018-06-30 | 2018-09-10 | $5.42 million | -$0.37 | -$0.33 | -13.85% |
2018-03-31 | 2018-05-08 | $3.6 million | -$0.45 | -$0.39 | -14.8% |
2017-12-31 | 2018-02-09 | $4.85 million | -$0.29 | -$0.18 | -64.77% |
2017-09-30 | 2017-11-07 | $10.32 million | -$0.08 | -$0.13 | 36% |
2017-06-30 | 2017-09-13 | $8.35 million | -$0.18 | -$0.08 | -140% |
2017-03-31 | 2017-05-10 | $8.39 million | -$0.05 | $0.07 | -174.07% |
2016-12-31 | 2017-02-08 | $10.93 million | $0.11 | $0.04 | 193.33% |
2016-09-30 | 2016-11-08 | $11.81 million | $0.20 | -$0.01 | 2100% |
2016-06-30 | 2016-09-12 | $12.11 million | $0.15 | $0.08 | 95.57% |
2016-03-31 | 2016-05-09 | $12 million | $0.11 | $0.17 | -35.29% |
2015-12-31 | 2016-02-08 | $12.19 million | $0.17 | -$0.34 | 149.64% |
2015-09-30 | 2015-11-05 | $11.06 million | -$0.53 | -$0.19 | -178.95% |
2015-06-30 | 2015-09-10 | $713000 | -$0.48 | -$0.40 | -20% |
2015-03-31 | 2015-05-11 | $284000 | -$0.38 | -$0.33 | -15.15% |
2014-12-31 | 2015-02-11 | $652000 | -$0.28 | -$0.38 | 26.32% |
2014-09-30 | 2014-11-12 | $705000 | -$0.34 | -$0.29 | -17.24% |
2014-06-30 | 2014-09-26 | $124000 | -$0.32 | -$0.35 | 8.57% |
2014-03-31 | 2014-05-14 | $232000 | -$25.45 | -$0.37 | -6778.38% |
Applied Genetic Technologies Corporation (AGTC) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Applied Genetic Technologies Corporation (AGTC) Chart:
Applied Genetic Technologies Corporation (AGTC) News:
Below you will find a list of latest news for Applied Genetic Technologies Corporation (AGTC) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Applied Genetic Technologies Corporation (AGTC) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest AGTC Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:50 PM EST | 100 | $0.8371 |
Jun 13, 2022 7:54 PM EST | 100 | $0.8374 |
Jun 13, 2022 7:57 PM EST | 200 | $0.8375 |
Jun 13, 2022 7:58 PM EST | 100 | $0.8437 |
Jun 13, 2022 7:59 PM EST | 1 | $0.84 |
Applied Genetic Technologies Corporation (AGTC) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520186812/0001193125-20-186812-index.htm |
2020-02-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1273636/000000000020001069/0000000000-20-001069-index.htm |
2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000089924320021803/0000899243-20-021803-index.htm |
2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000089924320021805/0000899243-20-021805-index.htm |
2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000089924320021807/0000899243-20-021807-index.htm |
2020-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000089924320021811/0000899243-20-021811-index.htm |
2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000103738920000095/0001037389-20-000095-index.htm |
2019-03-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000110465919017442/0001104659-19-017442-index.htm |
2019-11-21 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000110465919066219/0001104659-19-066219-index.htm |
2019-11-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000110465919067696/0001104659-19-067696-index.htm |
2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000110465919067700/0001104659-19-067700-index.htm |
2019-12-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000110465919076800/0001104659-19-076800-index.htm |
2020-01-27 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000110465920007216/0001104659-20-007216-index.htm |
2020-09-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000110465920109236/0001104659-20-109236-index.htm |
2018-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312518233245/0001193125-18-233245-index.htm |
2018-08-02 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312518235147/0001193125-18-235147-index.htm |
2018-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312518281373/0001193125-18-281373-index.htm |
2018-10-16 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1273636/000119312518300301/0001193125-18-300301-index.htm |
2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312518321849/0001193125-18-321849-index.htm |
2018-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1273636/000119312518323809/0001193125-18-323809-index.htm |
2018-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312518330330/0001193125-18-330330-index.htm |
2018-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312518348318/0001193125-18-348318-index.htm |
2019-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312519030172/0001193125-19-030172-index.htm |
2019-02-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1273636/000119312519030848/0001193125-19-030848-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000119312519040572/0001193125-19-040572-index.htm |
2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312519138835/0001193125-19-138835-index.htm |
2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1273636/000119312519139735/0001193125-19-139735-index.htm |
2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312519180690/0001193125-19-180690-index.htm |
2019-07-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312519203040/0001193125-19-203040-index.htm |
2019-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312519212072/0001193125-19-212072-index.htm |
2019-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312519255961/0001193125-19-255961-index.htm |
2019-09-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1273636/000119312519255968/0001193125-19-255968-index.htm |
2019-09-26 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1273636/000119312519255981/0001193125-19-255981-index.htm |
2019-09-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1273636/000119312519255990/0001193125-19-255990-index.htm |
2019-10-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1273636/000119312519277798/0001193125-19-277798-index.htm |
2019-11-04 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1273636/000119312519283531/0001193125-19-283531-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312519290059/0001193125-19-290059-index.htm |
2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1273636/000119312519290072/0001193125-19-290072-index.htm |
2019-12-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312519304427/0001193125-19-304427-index.htm |
2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312519309304/0001193125-19-309304-index.htm |
2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520005429/0001193125-20-005429-index.htm |
2020-01-29 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1273636/000119312520018614/0001193125-20-018614-index.htm |
2020-02-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1273636/000119312520025374/0001193125-20-025374-index.htm |
2020-02-05 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1273636/000119312520025421/0001193125-20-025421-index.htm |
2020-02-05 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1273636/000119312520025472/0001193125-20-025472-index.htm |
2020-02-05 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1273636/000119312520025478/0001193125-20-025478-index.htm |
2020-02-07 | POS EX | Post-effective amendment adding exhibits to registration statement [Rule 462(d)] | https://www.sec.gov/Archives/edgar/data/1273636/000119312520027055/0001193125-20-027055-index.htm |
2020-02-07 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1273636/000119312520028177/0001193125-20-028177-index.htm |
2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000119312520031460/0001193125-20-031460-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000119312520036614/0001193125-20-036614-index.htm |
2020-04-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520099924/0001193125-20-099924-index.htm |
2020-04-08 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520101339/0001193125-20-101339-index.htm |
2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520141033/0001193125-20-141033-index.htm |
2020-05-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1273636/000119312520141610/0001193125-20-141610-index.htm |
2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520186812/0001193125-20-186812-index.htm |
2020-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520196790/0001193125-20-196790-index.htm |
2020-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520213063/0001193125-20-213063-index.htm |
2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520215552/0001193125-20-215552-index.htm |
2020-09-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520241522/0001193125-20-241522-index.htm |
2020-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000119312520248061/0001193125-20-248061-index.htm |
2020-09-18 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1273636/000119312520249103/0001193125-20-249103-index.htm |
2020-09-18 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1273636/000119312520249106/0001193125-20-249106-index.htm |
2020-11-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1273636/000119312520283941/0001193125-20-283941-index.htm |
2020-11-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1273636/000119312520283945/0001193125-20-283945-index.htm |
2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000125889719001012/0001258897-19-001012-index.htm |
2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000125889720000783/0001258897-20-000783-index.htm |
2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000020/0001273636-18-000020-index.htm |
2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000022/0001273636-18-000022-index.htm |
2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000024/0001273636-18-000024-index.htm |
2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000026/0001273636-18-000026-index.htm |
2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000028/0001273636-18-000028-index.htm |
2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000030/0001273636-18-000030-index.htm |
2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000032/0001273636-18-000032-index.htm |
2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000034/0001273636-18-000034-index.htm |
2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000036/0001273636-18-000036-index.htm |
2018-07-30 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000038/0001273636-18-000038-index.htm |
2018-07-30 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000040/0001273636-18-000040-index.htm |
2018-07-30 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000042/0001273636-18-000042-index.htm |
2018-07-30 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000044/0001273636-18-000044-index.htm |
2018-07-30 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000046/0001273636-18-000046-index.htm |
2018-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000049/0001273636-18-000049-index.htm |
2018-09-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000051/0001273636-18-000051-index.htm |
2018-09-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000054/0001273636-18-000054-index.htm |
2018-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000056/0001273636-18-000056-index.htm |
2018-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000058/0001273636-18-000058-index.htm |
2018-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000060/0001273636-18-000060-index.htm |
2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000063/0001273636-18-000063-index.htm |
2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000065/0001273636-18-000065-index.htm |
2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000067/0001273636-18-000067-index.htm |
2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000071/0001273636-18-000071-index.htm |
2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000073/0001273636-18-000073-index.htm |
2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000075/0001273636-18-000075-index.htm |
2018-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000077/0001273636-18-000077-index.htm |
2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000079/0001273636-18-000079-index.htm |
2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000081/0001273636-18-000081-index.htm |
2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000083/0001273636-18-000083-index.htm |
2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/0001273636-18-000085-index.htm |
2018-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000087/0001273636-18-000087-index.htm |
2019-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000003/0001273636-19-000003-index.htm |
2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000006/0001273636-19-000006-index.htm |
2019-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000008/0001273636-19-000008-index.htm |
2019-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000009/0001273636-19-000009-index.htm |
2019-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000010/0001273636-19-000010-index.htm |
2019-05-20 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000011/0001273636-19-000011-index.htm |
2019-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000012/0001273636-19-000012-index.htm |
2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000015/0001273636-19-000015-index.htm |
2019-06-20 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000017/0001273636-19-000017-index.htm |
2019-07-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000019/0001273636-19-000019-index.htm |
2019-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000022/0001273636-19-000022-index.htm |
2019-07-31 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000024/0001273636-19-000024-index.htm |
2019-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000026/0001273636-19-000026-index.htm |
2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000032/0001273636-19-000032-index.htm |
2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000033/0001273636-19-000033-index.htm |
2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000034/0001273636-19-000034-index.htm |
2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000035/0001273636-19-000035-index.htm |
2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000036/0001273636-19-000036-index.htm |
2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000039/0001273636-19-000039-index.htm |
2019-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000041/0001273636-19-000041-index.htm |
2019-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000043/0001273636-19-000043-index.htm |
2019-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000045/0001273636-19-000045-index.htm |
2019-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000047/0001273636-19-000047-index.htm |
2019-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000050/0001273636-19-000050-index.htm |
2019-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000052/0001273636-19-000052-index.htm |
2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363620000004/0001273636-20-000004-index.htm |
2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000127363620000005/0001273636-20-000005-index.htm |
2020-06-19 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1273636/000131924420000092/0001319244-20-000092-index.htm |
2020-02-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1273636/000138713120001829/0001387131-20-001829-index.htm |
2018-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1273636/000156459018022873/0001564590-18-022873-index.htm |
2018-09-11 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1273636/000156459018022913/0001564590-18-022913-index.htm |
2019-04-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000177378219000001/0001773782-19-000001-index.htm |
2019-04-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000177378219000002/0001773782-19-000002-index.htm |
2019-05-08 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1273636/000177378219000003/0001773782-19-000003-index.htm |
2020-02-06 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1273636/999999999520000282/9999999995-20-000282-index.htm |
2020-01-16 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1273636/999999999720000128/9999999997-20-000128-index.htm |
Applied Genetic Technologies Corporation (AGTC) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Applied Genetic Technologies Corporation (AGTC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 102%Institutional Ownership: 6832%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-12-14 | Mark S Shearman | Chief Scientific Officer | Sell | 3,000.00 | 3.35 | 10,052.70 | 0.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000081/0001273636-18-000081-index.htm |
2018-12-14 | James Rosen | Director | Buy | 1,000.00 | 3.38 | 3,381.00 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000087/0001273636-18-000087-index.htm |
2019-12-26 | Patrick Johan Hendrik Krol | 10% Share Holder | Sell | 81,162.00 | 5.24 | 425,288.88 | 1,780,762.00 | https://www.sec.gov/Archives/edgar/data/1273636/000110465919076800/0001104659-19-076800-index.htm |
2019-11-19 | Patrick Johan Hendrik Krol | 10% Share Holder | Buy | 2,544.00 | 2.79 | 7,097.76 | 1,861,924.00 | https://www.sec.gov/Archives/edgar/data/1273636/000110465919067700/0001104659-19-067700-index.htm |
2018-12-14 | Susan B. Washer | President and CEO | Buy | 2,380.00 | 3.34 | 7,949.20 | 22,708.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000079/0001273636-18-000079-index.htm |
2019-09-18 | Susan B. Washer | President and CEO | Buy | 5,700.00 | 3.50 | 19,950.00 | 28,408.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000039/0001273636-19-000039-index.htm |
2018-12-14 | William A. Sullivan | Chief Financial Officer | Buy | 3,000.00 | 3.33 | 9,990.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000083/0001273636-18-000083-index.htm |
2019-05-28 | Scott Koenig | Director | Buy | 32,018.00 | 0.35 | 11,206.30 | 34,246.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000012/0001273636-19-000012-index.htm |
2018-12-14 | William Aliski | Director | Buy | 1,200.00 | 3.24 | 3,882.00 | 3,700.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/0001273636-18-000085-index.htm |
2019-08-15 | Mark S Shearman | Chief Scientific Officer | Buy | 39,000.00 | 39,000.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000035/0001273636-19-000035-index.htm | ||
2019-08-15 | Stephen W Potter | VP and Chief Business Officer | Buy | 39,000.00 | 40,400.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000034/0001273636-19-000034-index.htm | ||
2018-08-13 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 41,976.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000049/0001273636-18-000049-index.htm | ||
2018-09-11 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 43,384.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000051/0001273636-18-000051-index.htm | ||
2018-10-11 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 44,699.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000058/0001273636-18-000058-index.htm | ||
2018-11-12 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 46,087.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000060/0001273636-18-000060-index.htm | ||
2018-12-11 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 47,402.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000077/0001273636-18-000077-index.htm | ||
2019-01-11 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 48,791.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000003/0001273636-19-000003-index.htm | ||
2019-02-11 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 50,078.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000006/0001273636-19-000006-index.htm | ||
2019-03-11 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 51,287.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000008/0001273636-19-000008-index.htm | ||
2019-04-11 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 52,620.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000009/0001273636-19-000009-index.htm | ||
2019-05-13 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 54,014.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000010/0001273636-19-000010-index.htm | ||
2019-06-11 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 55,329.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000015/0001273636-19-000015-index.htm | ||
2019-07-11 | Matthew Feinsod | Interim Chief Medical Officer | Buy | 2,000.00 | 56,644.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363619000019/0001273636-19-000019-index.htm | ||
2018-12-14 | William Aliski | Director | Buy | 4,300.00 | 3.25 | 13,975.00 | 8,000.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/0001273636-18-000085-index.htm |
2018-12-14 | William Aliski | Director | Buy | 500.00 | 3.24 | 1,620.00 | 8,500.00 | https://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/0001273636-18-000085-index.htm |